Post

AstraZeneca ends Phase IV Andexxa trial after positive results

AstraZeneca has announced it would stop Andexxa’s Phase IV trial after the study achieved its aims earlier than expected. The ANNEXA-I …

EU agencies back Covid-19 vaccine update ahead of autumn campaign

Covid-19 vaccine compositions should be updated to provide protection against XBB Omicron variant strains in preparation for the autumn vaccination …

Baudax Bio reports promising additional data for neuromuscular blockade agent

Baudax Bio revealed has additional results from a Phase II trial investigating its neuromuscular blockade (NMD) agent BX1000 in patients …

ZyVersa Therapeutics inches closer to European patent approval for VAR 200

ZyVersa Therapeutics has received a notice of intention to grant from the European Patent Office for its patent application for …

Fosun Pharma and IFC to build new drug manufacturing plant in Africa

Shanghai Fosun Pharmaceutical (Group) is to collaborate with the International Finance Corporation (IFC) to construct a new pharmaceutical production facility …